Partha Roy

Prof. Dr. Partha Roy


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SDSuvadra Das
Suvadra Das
PRPartha Roy
Partha Roy
SMSubhasish Mondal
Subhasish Mondal
TBTanmoy Bera
Tanmoy Bera
AMArup Mukherjee
Arup Mukherjee

3 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SDSuvadra Das
Suvadra Das
PRPartha Roy
Partha Roy
RPRajat Pal
Rajat Pal
RARuna Ghosh Auddy
Runa Ghosh Auddy
ACAbhay Sankar Chakraborti
Abhay Sankar Chakraborti
AMArup Mukherjee
Arup Mukherjee
Silybin, is one imminent therapeutic for drug induced hepatotoxicity, human prostrate adenocarcinoma and other degenerative organ diseases. Recent evidences suggest that silybin influences gluconeogenesis pathways favorably and is beneficial in the treatment of type 1 and type 2 diabetes. The compound however is constrained due to solubility (0.4 mg/mL) and bioavailabilty limitations. Appropriate nanoparticle design for silybin in biocompatible polymers was thus proposed as a probable solution for therapeutic inadequacy. New surface engineered biopolymeric nanoparticles with high silybin encapsulation efficiency of 92.11% and zeta potential of +21 mV were designed. Both the pure compound and the nanoparticles were evaluated in vivo for the first time in experimental diabetic conditions. Animal health recovered substantially and the blood glucose levels came down to near normal values after 28 days treatment schedule with the engineered nanoparticles. Restoration from hyperglycemic damage condition was traced to serum insulin regeneration. Serum insulin recovered from the streptozotocin induced pancreatic damage levels of 0.17±0.01 µg/lit to 0.57±0.11 µg/lit after nanoparticle treatment. Significant reduction in glycated hemoglobin level, and restoration of liver glycogen content were some of the other interesting observations. Engineered silybin nanoparticle assisted recovery in diabetic conditions was reasoned due to improved silybin dissolution, passive transport in nanoscale, and restoration of antioxidant status.

17 April 2024 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
SMSuvadeep Mal
Suvadeep Mal
SCSubhasis Chakraborty
Subhasis Chakraborty
MMMonalisa Mahapatra
Monalisa Mahapatra
KPKakarla Pakeeraiah
Kakarla Pakeeraiah
SDSuvadra Das
Suvadra Das
PRPartha Roy
Partha Roy
From HAuCl4, nano-gold is synthesized via physical, chemical and green techniques. Systematic engineering with different functionalities shapes nano-gold into a sword with multimodal applicability against breast cancer, but what are the consequences?

15 January 2013 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
PRPartha Roy
Partha Roy
SDSuvadra Das
Suvadra Das
RARuna Ghosh Auddy
Runa Ghosh Auddy
ASAchintya Saha
Achintya Saha
AMArup Mukherjee
Arup Mukherjee

1 December 2010 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AMArup Mukherjee
Arup Mukherjee
PRPartha Roy
Partha Roy
SDSuvadra Das
Suvadra Das
TBTanmoy Bera
Tanmoy Bera
SMSubhasis Mondol
Subhasis Mondol
Andrographolide (AG) is a diterpenoid lactone isolated from the leaves of Andrographis paniculata. AG is a potent and low-toxicity antileishmanial agent. Chemotherapy applications of AG are, however, seriously constrained because of poor bioavailability, short plasma half-life, and inappropriate tissue localization. Nanoparticulation of AG was therefore envisaged as a possible solution. AG nanoparticles (AGnp) loaded in 50:50 poly(DL-lactide-co-glycolic acid) were prepared for delivery into the monocyte–macrophage cells infested with the amastigote form of leishmanial parasite for evaluation in the chemotherapy of leishmaniasis. Particle characteristics of AGnp were optimized by proportionate application of a stabilizer, polyvinyl alcohol (PVA). Physicochemical characterization of AGnp by photon correlation spectroscopy exhibited an average particle size of 173 nm and zeta potential of -34.8 mV. Atomic force microscopy visualization revealed spherical nanoparticles with a smooth surface. Antileishmanial activity was found to be significant for the nanoparticle preparation with 4% PVA (IC50 34 µM) in about one-fourth of the dosage of the pure compound AG (IC50 160 µM). AGnp therefore have significant potential to target the infested macrophage cells and prove valuable in chemotherapy of neglected tropical diseases such as leishmaniasis.

1 October 2018 in Cytokine
Verified
Journal Article
Closed access
AHAsim Halder
Asim Halder
DSDivanshu Shukla
Divanshu Shukla
SDSuvadra Das
Suvadra Das
PRPartha Roy
Partha Roy
AMArup Mukherjee
Arup Mukherjee
BSBhaskar Saha
Bhaskar Saha